MODD

Modular Medical, Inc.
CAPPED RATING

Modular Medical, Inc., a development stage medical device company, focuses on the design, development, and commercialization of insulin pumps using technology to enhance pump adoption in the diabetes marketplace. The company is headquartered in San Diego, California.

Modular Medical, Inc. (MODD) is rated C (2.2/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Revisions (C+); its weakest is Momentum (D+). The rating has held at C for 5 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.2 / 5.0
C
Value
C+
Factor Score 2.5 / 5.0
Growth
C+
Factor Score 2.5 / 5.0
Profitability
C-
Factor Score 2.0 / 5.0
Momentum
D+
Factor Score 1.5 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio -3.3
EV / EBITDA -0.4
Rev Growth YoY N/A
Gross Margin 0.0%
Price Return 3M -32.1%
Price Return 12M -88.5%
Catalyst Signal 0.00
Market Cap $16.0M
TTM Revenue N/A
Price / Sales N/A
ROE -247.9%

Historical Factor Score Progression

Held C for 5 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-13 C+ (2.5) C+ (2.5) C- (2.0) D+ (1.5) C+ (2.6) C (2.2)
2026-11-06 C+ (2.5) C+ (2.5) C- (2.1) D (1.4) C+ (2.7) C (2.2)
2026-10-30 C+ (2.5) C+ (2.5) C (2.2) D (1.4) C+ (2.7) C (2.2)
2026-10-23 C+ (2.5) C+ (2.5) C- (2.1) D (1.4) C+ (2.6) C (2.2)
2026-10-16 C+ (2.5) C+ (2.5) C- (2.1) D (1.4) C+ (2.6) C (2.2)
Page 1 of 3